olmesartan medoxomil has been researched along with Fetal Growth Restriction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukamizu, A; Hashimoto, M; Ishida, J; Ishimaru, T; Kunita, S; Matsukura, T; Nakamura, A; Nakamura, S; Sugiyama, F; Yagami, K | 1 |
1 other study(ies) available for olmesartan medoxomil and Fetal Growth Restriction
Article | Year |
---|---|
Short-term suppression of the renin-angiotensin system in mice associated with hypertension during pregnancy.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Female; Fetal Growth Retardation; Hypertension, Pregnancy-Induced; Imidazoles; Male; Mice; Mice, Inbred C57BL; Olmesartan Medoxomil; Placenta; Pregnancy; Renin-Angiotensin System; Tetrazoles; Time Factors; Ventricular Remodeling | 2012 |